Brian McNabb

Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis

Rafael Esteban, Juan A. Pineda, José Luís Calleja et al. · Gastroenterology · 2018 · 94 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +14

Sofosbuvir/velpatasvir for 12 weeks in genotype 1–4 HCV-infected liver transplant recipients

Kosh Agarwal, Lluı́s Castells, Beat Müllhaupt et al. · Journal of Hepatology · 2018 · 73 citations

Medicine, Infectious Diseases, Pharmacotherapy +16

BMD changes and predictors of increased bone loss in postmenopausal women after a 5-year course of alendronate

Brian McNabb, Eric Vittinghoff, Ann V. Schwartz et al. · Journal of Bone and Mineral Research · 2013 · 58 citations

Medicine, Orthopedic Surgery, Bone Augmentation +16

Sofosbuvir–velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals

Namiki Izumi, Tetsuo Takehara, Kazuaki Chayama et al. · Hepatology International · 2018 · 51 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Comparison of BMD Changes and Bone Formation Marker Levels 3 Years After Bisphosphonate Discontinuation: FLEX and HORIZON-PFT Extension I Trials

Tiffany Y. Kim, Douglas C. Bauer, Brian McNabb et al. · Journal of Bone and Mineral Research · 2018 · 35 citations · Full text

Pharmacy, Pharmacotherapy, Bone Augmentation +16